投稿须知/期刊简介:

The&nbsp;European Journal of Pharmaceutics and Biopharmaceutics&nbsp;provides a medium for publication of novel and innovative research from the areas of Pharmaceutical Technology, Pharmaceutical Biotechnology and Biopharmaceutics. Topics covered include: • Drug and pro-drug design, drug stability and drug development<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> • Development, formulation and manufacturing of pharmaceuticals and biopharmaceuticals<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> • Physical pharmacy, drug delivery systems, controlled release systems and drug targeting<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> • Biopharmaceutics<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> • Pharmaceutical analysis and pharmaceutical packaging<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> • Quality control, GMP and regulatory aspects<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> • Medical devices "The Rules of 3"<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work: 1. The paper must report on recent advances in pharmaceutical technology, biopharmaceutics and pharmaceutical biotechnology of major importance<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> 2. A paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented.<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> 3. The study described in the manuscript must represent a novel approach The rules are also used as guidelines for the peer review of manuscripts.&nbsp;CLICK HERE&nbsp;to view the "Rules of 3".

期刊描述简介:

The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for publication of novel and innovative research from the areas of Pharmaceutical Technology, Pharmaceutical Biotechnology and Biopharmaceutics. Topics covered include: • Drug and pro-drug design, drug stability and drug development • Development, formulation and manufacturing of pharmaceuticals and biopharmaceuticals • Physical pharmacy, drug delivery systems, controlled release systems and drug targeting • Biopharmaceutics • Pharmaceutical analysis and pharmaceutical packaging • Quality control, GMP and regulatory aspects • Medical devices "The Rules of 3" The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work: 1. The paper must report on recent advances in pharmaceutical technology, biopharmaceutics and pharmaceutical biotechnology of major importance 2. A paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented. 3. The study described in the manuscript must represent a novel approach The rules are also used as guidelines for the peer review of manuscripts. CLICK HERE to view the "Rules of 3".